Huma Finance vs Mira — how do they compare? Huma Finance trades at Rp337.62 (market cap Rp1,1T, Rp79,92M 24h volume), while Mira trades at Rp700.16 (market cap Rp226,43M, Rp101,47M 24h volume). The key difference: Huma Finance is far larger — about 4858× Mira's market cap, and Huma Finance's circulating supply is 3,3B / 10B HUMA (33%) versus 321,5M / 1B MIRA (33%) for Mira. Which is the better fit depends on your goals — on Pluang, investors hold Huma Finance for 14 Days and Mira for 22 Days on average.
| HUMA | MIRA | |
|---|---|---|
Market Cap | Rp1,1T | Rp226,43M |
Volume (24h) | Rp79,92M | Rp101,47M |
Circulating Supply | 3,3B / 10B HUMA (33%) | 321,5M / 1B MIRA (33%) |
Typical Hold Time | 14 Days | 22 Days |
Signals from Pluang's Aura AI — not financial advice
HUMA is trading at Rp352.39 with a market cap of Rp1.15 trillion, showing a bearish technical signal from moving averages but neutral oscillators. The token is near its pivot point of Rp353, with support at Rp345 and resistance at Rp360. With 33% of its 10 million max supply circulating and an average hold time of 14 days, on-chain activity indicates moderate distribution. Recent ecosystem updates include protocol optimizations noted in community discussions (CoinGecko, 2026-08-12).
Overall outlook is cautious due to bearish technical pressure, though neutral RSI levels suggest potential stabilization. Key opportunities lie in network adoption growth if utility expands, but risks include high volatility and regulatory scrutiny common to crypto assets. Investors should monitor support levels for entry points.
MIRA token trades at Rp724 with bearish technical signals as moving averages indicate strong selling pressure. The token shows neutral oscillators but faces resistance at Rp726-758 levels. With 33% circulating supply and 22-day average hold time, market participation remains limited. Recent ecosystem developments show progress in pharmaceutical research applications, though direct token utility updates are scarce.
Overall outlook remains cautious due to technical bearishness and limited trading volume. Key opportunity lies in potential protocol adoption from pharmaceutical research partnerships. Major risks include low liquidity, high volatility, and regulatory uncertainty surrounding crypto-pharma intersections. Investors should monitor exchange listings and token utility expansion.
What Pluang investors did over the last 30 days
Huma Finance is the first PayFi network that provides global payment financing with instant, on-demand liquidity—available anytime and anywhere. It enables payment institutions around the world to settle transactions 24/7 using stablecoins and on-chain liquidity. Huma supports a wide variety of PayFi use cases, including cross-border payments, credit card settlements, and trade finance, while also facilitating emerging solutions such as decentralized physical infrastructure network (DePIN) financing.
Read more on HUMA →Mira is a decentralized verification network that enables autonomous AI by eliminating human oversight. Using consensus-based verification across multiple AI models, Mira delivers mathematically verifiable and trustless results in real time. This ensures accuracy and reliability for critical fields like healthcare, finance, and law—transforming AI from a supervised tool into truly independent intelligence.
Read more on MIRA →